Level Four Advisory Services, LLC Regenxbio Inc. Transaction History

Level Four Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $114,810 - $289,428	-5,340 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$34.54 - $44.87 $11,052 - $14,358	-320 Reduced 5.65%	5,340 $218,000
Q3 2019 Nov 12, 2019	BUY	$31.84 - $50.88 $15,760 - $25,185	495 Added 9.58%	5,660 $201,000
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $3,990 - $5,632	95 Added 1.87%	5,165 $265,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $206,957 - $316,621	5,070 New	5,070 $291,000

191

45.4M

184K

56.7K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $355M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.